Incubate advocates for the patient, corporate, and investment communities by educating policymakers on the role of venture capital in bringing promising, innovative treatments to patients in need.
What We Do
Help ensure a level global playing field for investment and promote policies that empower life science innovators to build and grow in the United States.
Strengthen and protect U.S. intellectual property provisions by promoting patent and regulatory systems that encourage life sciences innovation.
Amplify the results
Spotlight the venture capital-driven breakthroughs that are transforming medicine for patients and health professionals around the globe.
Massachusetts Biotech Community Calls on Congress to Fix the Small Molecule Penalty
Given the tremendous focus of MA-based companies and investors, we had an opportunity to pen some thoughts which are shared in the attached letter.
From Bad to Worse on Drug Price Controls
The life sciences venture capital community has long warned against the adverse consequences government price controls for prescription drugs would…
EPISODE 21- Making Patients the Center of U.S. Healthcare Reform
In this episode, MacKay Jimeson, Executive Director of The Patient Access & Affordability Project at Patients Rising, joins the show to explain how the system was never designed for patients, the benefits of a patient-centric system, and what the future holds for the industry.
Stories from the Early-Stage Life Sciences Ecosystem
Listen to industry experts delve into the process behind scientific breakthroughs (and how many of them almost never happened), where the life science ecosystem is taking us next, and most importantly, what it means for patients.
Global Health Idea Lab Virtual Summit
Join our Virtual Summit as we embrace and nurture diverse talents, creativity, curiosity, and collaboration. We dive deep into the…